(by David Knight, IW) -- Is convalescent serum unproven as the WHO says? It’s a treatment technique that’s been used effectively for 124 years, called passive immunity.
Dr. Kent Brantley and others who have contracted Ebola have been eager to receive and to pass on blood from survivors of Ebola. He received blood plasma antibodies from a patient he treated in Africa that survived. After Dr. Brantley survived, he donated plasma antibodies to the next American doctor to be infected, Dr. Sacra who also recovered. Brantley has also donated blood to two others who are still fighting Ebola: Ashoka Kukpo, the NBC cameraman, and Nina Pham the first Dallas nurse to contract the disease.
Brantley is not the only medical worker who appears to believe the treatment is effective. Will Pooley, the British nurse who survived Ebola, flew to Atlanta to offer his blood and a Spanish Ebola survivor flew to Spain to give her blood to a Spanish priest with Ebola, but arrived too late.
In Africa, demand for survivors’ blood has created a “black market” that the World Health Organization (WHO) says needs to be shut down with help from governments.
The WHO said months ago that the treatment is “unproven” but “promising” and that they need to “look into” it someday.
Still no word on when that’s going to happen.
As mainstream media casts doubt on convalescent serum’s effectiveness, it promotes the GMO drug ZMapp as a “miracle”.
Mass production of the GMO drug is ramping up with funding from the Gates Foundation, and the bio-pharmaceutical industry.
Which begs the questions: why develop a GMO imitation if the human version is “unproven” and why delay treatment when a large supply of convalescent serum is now available from survivors?